Market
Scenario:
The cervix is the lower part of
the uterus that connects to the vagina. Cervical cancer develops in the cells
of the cervix. Strains of Human Papillomavirus (HPV), a sexually transmitted
infection, play a role in causing most of the cervical cancers. The disease
begins when healthy cells acquire mutation leading to the uncontrolled growth
of cells. These cells form a tumor which invades the nearby tissues. Squamous
cell carcinomas, adenocarcinomas, and adenosquamous carcinomas are three types
of cervical cancers. Squamous cell carcinomas develop from cells in the
exocervix while adenocarcinomas develop from gland cells. The cancer cells are
said to have features of squamous cells under the microscope. Adenosquamous
carcinomas feature both squamous cell carcinomas and adenocarcinomas.
Cryosurgery, laser surgery, simple hysterectomy, radical hysterectomy, and
trachelectomy are various treatment options for cervical cancer. Cystoscopy,
proctoscopy, examination under anesthesia, and imaging studies such as Computed
Tomography (CT), Magnetic Resonance Imaging (MRI), intravenous urography, and
Positron Emission Tomography (PET scan) are used of the diagnosis of cervical
cancer.
The cervical cancer treatment
market is mainly driven by the increasing prevalence of cervical cancer and
increasing awareness about cervical cancer among women. Furthermore, the
increasing demand for early diagnosis and treatment of cervical cancer is also
expected to fuel the growth of the market during the review period. However,
the high cost of treatment also fuels the growth of the market. The World
Health Organization (WHO) stated that cancer was the leading cause of the total
number of deaths globally in 2015 and was responsible for 8.8 million deaths.
Global Cervical Cancer Treatment
market is expected to grow at a CAGR of 6.5% during the forecast period.
Segments
The global cervical cancer treatment market is
segmented on the basis of type, treatment, and end-user.
On the basis of type, the market is segmented into
squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas.
On the basis of treatment, the market is segmented
into surgery, radiation therapy, chemotherapy, targeted therapy, hormone
therapy, and others.
Surgery is further segmented into cryosurgery,
laser surgery, simple hysterectomy, radical hysterectomy, trachelectomy, and
others.
Radiation Therapy is further segmented into
external beam radiation and brachytherapy
Chemotherapy is further segmented into cisplatin,
carboplatin, paclitaxel, doxorubicin, gemcitabine, bevacizumab, and others.
Targeted therapy is further segmented into
bevacizumab and pazopanib.
Hormone therapy is further segmented into oestrogen,
progesterone, progestogens, and testosterone.
On the basis of end-user, the market is segmented
into cancer care centers, diagnostic centers, pharmacies, and others.
Regional Analysis of the Global Cervical Cancer
Treatment
Market
Globally, Americas is the largest market for
cervical cancer treatment whose growth is attributed to technological
advancements in the field of oncology, increasing prevalence of cervical
cancer, and development of new imaging devices by key players in the market. In
North America, the market is driven by the increasing awareness of causes and
risk factors of cervical cancer and its treatment. In the U.S., the market is
driven by the increasing importance of women healthcare and changing lifestyle
of women. South America exhibits a steady growth in the cervical cancer
treatment market.
In Asia Pacific, the cervical cancer treatment
market exhibits numerous growth opportunities due to rising awareness about
cervical cancer and the increasing demand for cost-effective treatment
solutions such as chemotherapy. Japan, China, and India are the largest
contributors to the market growth where the market is driven by the increasing
emphasis on cancer detection and treatment and the rising prevalence of cancer.
Additionally, availability of skilled healthcare professionals in research also
accelerates the growth of the market. The increasing government support of
oncology research and women healthcare initiatives and the rapid growth of the
healthcare imaging industry in India and China fuel the f=growth of the market
in the regions.
In the European countries, the growth of the market
is attributed to a number of healthcare institutions offering treatment of
cancer and huge investments in research and development activities by the U.K.
and Germany. In Germany, the market is mainly driven by an increase in the use
of new technological devices for the diagnosis and treatment of cancer.
In the Middle East, Saudi Arabia and the United
Arab Emirates (U.A.E.) are the largest contributors to the market growth due to
the focus on the development of new healthcare facilities catering to the needs
of cancer patients and availability of technologically advanced diagnostic
devices of management. In African countries, the increasing number of
healthcare initiatives for women health and improvement in healthcare
infrastructure are likely to boost the growth of the market.
Key Players in the Global Cervical Cancer Treatment
Market
Some of
the key players in this market are Pfizer Inc., GlaxoSmithKline, Bristol-Myers
Squibb Company, ALLERGAN, Actavis Pharma Company, Eli Lilly and Company,
Alnylam Pharmaceuticals, Inc, Hetero, Biocon, Novartis, Genentech USA, and
others.
Browse Complete 100 Pages Premium Research Report Enabled with
Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cervical-cancer-treatment-market-5834
Detailed Table of
Contents:
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
5 Global Cervical Cancer Treatment Market, By Material
5.1 Introduction
5.1.1 Synthetic Materials
5.1.2 Genetically Engineered Materials
5.1.3 Biologically Derived Materials
5.1.4 Others
...Continued
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune -
411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment